Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin
The cellular origin of clear cell ovarian carcinoma (CCOC), a major histological subtype of ovarian carcinoma remains elusive. Here, we explored the candidate cellular origin and identify molecular subtypes using integrated genomic/epigenomic analysis. We performed whole exome-sequencing, microarray, and DNA methylation array in 78 CCOC samples according to the original diagnosis. The findings revealed that ARID1A and/or PIK3CA mutations were mutually exclusive with DNA repair related genes, including TP53, BRCA1, and ATM. Clustering of CCOC and other ovarian carcinomas (n = 270) with normal tissues from the fallopian tube, ovarian surface epithelium, endometrial epithelium, and pelvic peritoneum mesothelium (PPM) in a methylation array showed that major CCOC subtypes (with ARID1A and/or PIK3CA mutations) were associated with the PPM-lile cluster (n = 64). This cluster was sub-divided into three clusters: (1) mismatch repair (MMR) deficient with tumor mutational burden-high (n = 2), (2) alteration of ARID1A (n = 51), and (3) ARID1A wild-type (n = 11). The remaining samples (n = 14) were subdivided into (4) ovarian surface epithelium-like (n = 11) and (5) fallopian tube-like (considered as high-grade serous histotype; n = 3). Among these, subtypes (1-3) and others (4 and 5) were found to be associated with immunoreactive signatures and epithelial-mesenchymal transition, respectively. These results contribute to the stratification of CCOC into biological subtypes.
Authors
- Hiroyuki Aburatani (ORCID: https://orcid.org/0000-0003-0438-1544)
- Yuji Ikeda (ORCID: https://orcid.org/0000-0003-1633-5385)
- Katsutoshi Oda (ORCID: https://orcid.org/0000-0002-2468-9573)
- Tetsuo Ushiku (ORCID: https://orcid.org/0000-0002-1763-8380)
- Akira Kurosaki (ORCID: https://orcid.org/0000-0002-2562-3840)
- Keiichi Fujiwara (ORCID: https://orcid.org/0000-0002-7388-0243)
- Genta Nagae (ORCID: https://orcid.org/0000-0002-2929-7990)
- Takahiro Koso
- Yutaka Osuga (ORCID: https://orcid.org/0000-0002-6660-1066)
- Ayumi Taguchi (ORCID: https://orcid.org/0000-0002-5491-3871)
- Shingo Tsuji (ORCID: https://orcid.org/0000-0002-0234-9519)
- Masako Ikemura (ORCID: https://orcid.org/0000-0002-7148-778X)
- Michihiro Tanikawa (ORCID: https://orcid.org/0000-0002-8669-7640)
- Mayuyo Mori
- Kenji Tatsuno (ORCID: https://orcid.org/0000-0002-3046-3941)
- Kosei Hasegawa (ORCID: https://orcid.org/0000-0002-1903-7001)
- Kenbun Sone (ORCID: https://orcid.org/0000-0002-7218-6401)
- Akira Nishijima (ORCID: https://orcid.org/0000-0002-5544-0543)
- Sho Sato (ORCID: https://orcid.org/0000-0001-5628-7141)
- Daichi Maeda (ORCID: https://orcid.org/0000-0002-9783-1534)
- Kayo Asada
- Yuriko Uehara
Institutions
- Kanazawa University (JP)
- Nihon University (JP)
- Tokyo University of Science (JP)
- The University of Tokyo (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Scientific Reports
- Published
- 2024-08-13
- DOI
- https://doi.org/10.1038/s41598-024-69796-4
- Citations
- 12
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.44
Funders
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science